Background: We tried to understand whether or not there are some relationships between irritable bowel syndrome (IBS), chronic gastritis (CG), depression, and various inflammatory processes in the body. Method: Consecutive patients with IBS age sex-matched control cases were included. Results: The study included 936 (592 females) 346 cases. Mean of was 41.0 years, 63.2% them female. Although ga...

introduction: dyspepsia, gastroesophageal reflux disease (gerd) and irritable bowel syndrome (ibs) are the most common gastrointestinal diseases. their prevalence is 18-30%, 25-30% and 10-15% in western communities and 8-14%, 3-7% and 3-5% in eastern countries, respectively. there is no adequate data about their prevalence in our country. the aim of this study is to determine the prevalence of ...

Background. The psychiatric disorders like anxiety and depression could have a profound influence on onset, expression, and course of Irritable bowel syndrome (IBS). Aim. To estimate the frequency and strength of association of common mental disorders (CMDs) in patients with IBS and patients with other chronic diseases, that is, migraine and hypertension. Method. This was a case control study. ...

background: migraine and irritable bowel syndrome (ibs) are chronic conditions that seem to share common pathophysiological aspects. objectives: our study aimed to estimate the prevalence of ibs in an iranian migraine population, investigate its association with headache's characteristics and depression. materials and methods: this cross-sectional study was done in a tertiary hospital clin...

Background & Aims: Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal functional disorder, characterized by non-specific symptoms such as abdominal pain and discomfort, altered bowel habit, and bloating. Its prevalence varies between 3.5% and 30% in the world. This study was conducted in order to determine the prevalence of IBS in the adult population of Kerman, Iran, which i...

OBJECTIVE To determine rates of faecal biomarker results capable of suggesting potentially treatable causes of irritable bowel syndrome (IBS) symptomatology in a population of patients with symptoms of IBS who meet Rome III criteria for that condition. DESIGN Descriptive, retrospective study in which faecal biomarker results (dichotomised into 'normal' and 'abnormal' values) were related to d...

Introduction: Irritable bowel syndrome (IBS) is one of the most common diseases affecting people around world. It characterized by irregular movements and abdominal pain. IBS significantly reduces quality life patients. Despite such a frequent occurrence this disease, its correct diagnosis treatment still causes many problems for primary care physicians. Aim study: The aim study to present curr...

background: the rome ii and iii diagnostic criteria for dyssynergic defecation recommended the exclusion of irritable bowel syndrome (ibs). this study determined the effect of biofeedback therapy on dyssynergic constipation in patients with or without  irritable bowel syndrome. materials and methods: this study was a non-randomized, single blinded, semi experimental study. dyssynergic defecatio...

BACKGROUND Irritable bowel syndrome has been reported as more common in patients with morbid obesity than in the general population. The reason for this association is unknown. The aims of this study were to study the prevalence of irritable bowel syndrome and other functional bowel disorders in patients with morbid obesity, and to search for predictors of irritable bowel syndrome. METHODS Pa...

Patients with irritable bowel syndrome (IBS) show a wide range of symptoms including diarrhea, abdominal pain, changes in bowel habits, nausea, vomiting, headache, anxiety, depression and cognitive impairment. Methylglyoxal has been proved to be a potential toxic metabolite produced by intestinal bacteria. The present study was aimed at investigating the correlation between methylglyoxal and ir...